Cerebral metastases as first symptom of cancer: A clinico-pathologic study

Journal of Neuro-Oncology

Volumn 50, Issue 3, 2000, Pages 265-273

  Giordana, M T ^a   Cordera, S ^a   Boghi, A ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

CEA; Cerebral metastases; Immunohistochemistry; k ras; p53

Indexed keywords

CARBOHYDRATE ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 20; GLYCOPROTEIN; MONOCLONAL ANTIBODY HMB 45; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; AUTOPSY; BRAIN METASTASIS; BREAST CARCINOMA; CANCER; CLINICAL EXAMINATION; FEMALE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; LUNG CARCINOMA; MALE; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MORPHOLOGY; NEUROPATHOLOGY; NEUROSURGERY; PROSTATE CARCINOMA; RETROSPECTIVE STUDY; SKIN CANCER; SYMPTOMATOLOGY;

ADULT; AGED; ANTIGENS, NEOPLASM; BRAIN NEOPLASMS; CARCINOEMBRYONIC ANTIGEN; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERMEDIATE FILAMENT PROTEINS; KERATIN-20; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASMS, UNKNOWN PRIMARY; PROGNOSIS; PROTO-ONCOGENE PROTEINS P21(RAS); RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034477893     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006413001375     Document Type: Article

References (30)

1. Brain metastases. Histology, multiplicity, surgery and survival
2. Single brain metastases from unknown primary malignancies in CT-era
3. Results and prognostic factors of surgery in the management of non-small cell lung cancer with solitary brain metastasis
4. Métastases cérébrales uniques des cancers broncho-pulmonaires
5. Sites of primary malignancies in patients presenting with cerebral metastases. A review of 120 cases
6. Brain metastases from undiagnosed systemic neoplasms
7. Brain metastases from an unknown primary tumour: Which diagnostic procedures are indicated?
8. Brain metastases as the only manifestation of an undetected primary tumor
9. Métastases de cancer à point de départ inconnue. Enseignement de 302 autopsies
10. Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site
11. Metastatic adenocarcinoma to the brain: An immunohistochemical approach
12. Detection of K-ras mutations in lung carcinomas: Relationship to prognosis
13. Analysis of K-ras gene mutations in lung carcinomas: Correlation with gender, histological subtypes, and clinical outcome
14. Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer
15. Immunohistochemical demonstration of prostate-specific antigen in metastases with the use of monoclonal antibody F5
16. Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes
17. Management of patients with brain metastases of unknown origin
18. Brain metastases from unknown primary site
19. Hirnmetastasen als erstmanifestation einer tumorerkrankung
20. Tumor marker immunoreactivity in adenocarcinoma
21. Poorly differentiated carcinoma of unknown primary site: Clinical usefulness of immunoperoxidase staining
22. Distribution of BCA-225 in adenocarcinomas. An immunohistochemical study of 446 cases
23. Carcinoembryogenetic antigen, a human tumor marker, functions as an intercellular adhesion molecule
24. The carcinoembryogenetic antigen (CEA) family: Structures, suggested functions and expression in normal and malignant tissues
25. p53 mutations in human cancer
26. Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer
27. p53 protein expression in central nervous system neoplasms
28. Analysis of p53 gene mutations in low- and high-grade astrocytomas by polymerase chain reaction-assisted single-strand conformation polymorphism and immunohistochemistry
29. Mutations and immunohistochemistry of p53 and proliferation markers in astrocytic tumors of childhood
30. Prognostic value of K-ras mutations, ras oncoprotein, and c-erb B-2 oncoprotein expression in adenocarcinoma of the lung